LifeStance Health Group, Inc. LFST NASDAQ

LifeStance Health Group, Inc. (LFST) reported strong year-over-year revenue growth of +13.9% through 2025-12 (TTM revenue vs prior-year TTM). Net income showed exceptional earnings expansion of +116.8% YoY, reaching $12M in the latest quarter. The net profit margin is 3.1%, which is thin. the company was profitable in 3 out of the last 4 quarters. The gross margin is 30.5% (moderate), up 2.8pp vs the prior year. With a $3B market cap, MOAT composite score of 60/100 (moderate competitive position).

Criteria proven by this page:

• GROWTH (90/100, Pass) — proving strong growth momentum
• PAST (25/100, Partial) — profitability has been inconsistent. Looking at the full 7-year annual history, the company was profitable in 2 of 7 years — a mixed long-term record
• INCOME (30/100, Partial) — the company is profitable but margin is below 15%
• MOAT (60/100, Partial) — some competitive advantages are present but not dominant

Overall SharesGrow Score: 59/100 with 2/7 criteria passed.